INFLUENCE OF HEPARINOID FROM PAEONIA LACTIFLORA ON HEMOSTATIC SYSTEM WITHIN CONDITIONS OF PRETHROMBOSIS


Cite item

Full Text

Abstract

The search and development of direct and rapid anticoagulants used per os, is an urgent problem in physiological and medical science. A number of plants contain heparin-like components with a positive effect on the hemostatic system, both within normal and in some pathological conditions of the body.The aim of the work was to study the complex effect of fibrin, a heparin-like substance (heparinoid) from the roots of Paeonia lactiflora, on fibrinolytic, anticoagulant systems of the body and polymerization processes, when it is administered per os in animals within normal conditions and when modeling the state of prethrombosis.Materials and methods. To carry out the research, the roots of Paeonia lactiflora growing in the Botanical Garden of Moscow State University, and laboratory animals - male Wistar rats - were used. To study the antithrombotic effects of the extract from roots containing heparinoid, the state of prethrombosis was modeled in rats. The determined parameters of hemostasis were: anticoagulant activity according to the tests of activated partial thromboplastin time and thrombin time, fibrinolytic activity according to the test of total fibrinolytic activity, fibrin polymerization according to the test of fibrindepolymerization activity of blood plasma.Results. With repeated (every 24 hours within 3 days) oral administration of the extract containing heparinoid, in animals within normal conditions and with prethrombosis, the following anticoagulant effects were established in the blood: an increase in anticoagulant, fibrindepolymerization and fibrinolytic plasma activity. Possible mechanisms of the activating effect of heparinoid on fibrinolysis and anticoagulant properties of plasma due to the excretion of tissue plasminogen activator into the bloodstream from the endothelium, thrombin inhibition, and fibrin polymerization are described. Moreover, the anticoagulant effect of the use of the extract from the peony roots was equivalent to that of the reference drug of low molecular weight heparin from Celsus (USA). For the first time, it was revealed that when modeling experimental prethrombosis, the administration of heparinoid in rats at the dose of 37.5 IU/kg МЕ/кг body weight restored impaired hemostasis, which requires a further study.Conclusion. The ability of heparinoid from peony roots to normalize the functional state of the anticoagulant system during the development of prethrombosis in animals has been established. The restriction of fibrin polymerization during oral administration of heparinoid from peony in animals by increasing the enzymatic fibrinolytic and fibrindepolymerization activity of blood plasma was revealed. In the future, heparinoid can be used as an antithrombotic agent.

About the authors

M. G. Lyapina

Lomonosov Moscow State University

Email: lyapinal@mail.ru

M. S. Uspenkaya

Lomonosov Moscow State University

Email: ms-uspenskaya@yandex.ru

E. S. Maistrenko

Lomonosov Moscow State University

Email: ms-uspenskaya@yandex.ru

M. D. Kalugina

Lomonosov Moscow State University

Email: laboratory7@mail.ru

References

  1. Buerke M., Hoffmeister H.M. Management of NOAK administration during invasive or surgical interventions. When and how to pause and when to restart? // Med Klin Intensivmed Notfmed. - 2017. - V. 112, N 2. - P. 105-110. doi: 10.1007/s00063-016-0240-2
  2. Кричевский Л.А. Низкомолекулярные гепарины в современной системе управления свертываемостью крови // Доктор.Ру. - 2015. - т. 117, №16. - С.42-48.
  3. Xiao C., Lian W., Zhou L., Gao N., Xu L., Chen J., Wu M., Peng W., Zhao J. Interactions between depolymerized fucosylated glycosaminoglycan and coagulation proteases or inhibitors // Thromb Res. - 2016. - V. 146. - P. 59-68. doi: 10.1016 / j.thromb. 2016.08.027.
  4. Hoppensteadt D.A., Fareed J. Pharmacological profile of sulodexide // Int Angiol. - 2014. - V. 33, N3. - P. 229-235.
  5. Milani M. Sulodexide: Review of recent clinical efficacy data // Online J. Medicine and Medical Science Research. -2013. - V. 2, N5. - Р. 57-61.
  6. González-Larrocha O., Salazar-Tafur M.F., Romero-Rojano P., Arízaga-Maguregui A. Sulodexide: a new antithrombotic agent. // Rev. Esp. Anestesiol. Reanim. -2017. - V. 64, N2: - P. 116. doi: 10.1016 / j.rev. 2016.09.007. Epub 2016
  7. Serra R, Gallelli L, Conti A, De Caridi G, Massara M, et al. The effect of sulodexide on both clinical and molecular parameters in patients with mixed arterial and venous ulcers of the lower extremities // Preparation Des Devel Ther. - 2014. - V. 8. - P. 519-527. doi: 10.2147 / DDDT. S61770. eCollection 2014.
  8. Ustyuzhanina N.Е., Bilan M.I., Gerbst A.G., Ushakova N.A., Tsvetkova E.A., Dmitrienko A.S., Usov A.I., Rifantiev A.E. Anticoagulant and antithrombotic activity of modified xylophone sulfate from the brown Alga Punctaria plantaginea // Carbohidr. Polym. - 2016 - V. 136. - P. 826- 833. doi: 10.1016 / j.cаrbоh .2015.09.102. Epub 2015.
  9. Bilan M.I., Shashkov A.S., Usov A.I. Structure of a sulfated xylofucan from the brown alga Punctaria plantaginea // Carbohydr Res. - 2014. - V. 393. - P. 1-8. doi: 10.1016/j. carres.2014.04.022
  10. Wu M., Xu L., Zhao L., Xiao C., Gao N., Luo L., Yang L., Li Z., Chen L., Zhao J. Structural analysis and anticoagulant activities of the novel sulfated fucan possessing a regular well-defined repeating unit from sea cucumber // Mar. Drugs. - 2015. - V. 13, N 4. - P. 2063-2084. doi: 10.3390 / md13042063.
  11. Zhang S.B. In vitro antithrombotic activities of peanut protein hydrolysates // Food Chem. - 2016. - V. 202. - P. 1-8. doi: 10.1016 / j.foodchem.2016.01.108. Epub 2016 27 yanv.
  12. Pomin V.H., Mourão P.A. Specific sulfation and glycosylation-a structural combination for the anticoagulation of marine carbohydrates // Front Cell Infect Microbiol. - 2014. - V. 4, N33. doi: 10.3389/ fcimb.2014.00033.
  13. Криштанов Н.А., Сафонова М.Ю., Болотова В.Ц., Павлова Е.Д., Саканян Е.И. Перспективы использования растительных полисахаридов в качестве лечебных и лечебно-профилактических средств // Вестник ВГУ, сер. Биология. Химия. Фармация. - 2005. - т. 1. - С. 212-221.
  14. Michel P., Owczarek A., Matczak M., Kosno M., Szymański P., Mikiciuk-Olasik E., Kilanowicz A., Wesołowski W., Olszewska M.A. Metabolite profiling of eastern teaberry (Gaultheria procumbens L.) lipophilic leaf extracts with hyaluronidase and lipoxygenase inhibitory activity // Molecules. - 2017. - V. 22, N 3. - P. E412-E414. doi: 10.3390/molecules22030412.
  15. Кузнецова С.А., Дрозд Н.Н., Кузнецов Б.Н., Макаров В.А., Левданский В.А., Мифтаков Н.т. Антикоагулянтное, средство // Патент № 2399377. Россия. 2009.
  16. Ляпина М.Г., Успенская М.С., Майстренко Е.С. О механизме антикоагулянтного действия экстракта из корней пиона молочноцветкового // Межд. журн. прикл. и фундамент. исследований. - 2016. - № 11. - C. 1091-1093.
  17. Ляпина Л.А., Григорьева М.Е., Оберган т.Ю., Шубина т.А. теоретические и практические вопросы изучения функционального состояния противосвертывающей системы крови. М. Адвансед Солюшнз. - 2012. - 160 с.
  18. Van Montfoort M L., Meijers J.C. Anticoagulation beyond direct thrombin and factor Xa inhibitors: indications for targeting theintrinsic pathway // Thromb. Haemost. - 2013. - V. 110, N 2. - P. 223-232. doi: 10.1160 / TH12-11-0803. Epub 2013 6 Jun..
  19. Nsimba M.M., Yamamoto C., Lami J.N., Hayakawa Y., Kaji T. Effect of a Congolese herbal medicine used in sickle cell anemia on the expression of plasminogen activators in human coronary aortic endothelial cells culture // J. Ethnopharmacol. - 2013. - V. 146, № 2. - P. 594-599. doi: 10.1016 / j.Ethnoph.2013.01.031. Epub 2013.
  20. Бышевский А.Ш., Галян С.Л., Калинин Е.П., Карпова И.А., Русакова О.А., Самойлов М.А., Созонюк А.Д., Сулкарнаева Г.А., тарасов Д.Б., чирятьев, Е.А.,Шаповалов П.Я.,.Шаповалова Е.М. Ингибиторы самосборки фибрина растительного происхождения // Медицинская наука и образование Урала. - 2012. - т. 13, № 1. - С. 163-170.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2019 Lyapina M.G., Uspenkaya M.S., Maistrenko E.S., Kalugina M.D.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
 

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).